Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients

J Immunol. 2015 Nov 1;195(9):4069-73. doi: 10.4049/jimmunol.1500940. Epub 2015 Sep 28.

Abstract

Sensitized recipients with pretransplant donor-specific Abs are at higher risk for Ab-mediated rejection than nonsensitized recipients, yet little is known about the properties of memory B cells that are central to the recall alloantibody responses. Using cell enrichment and MHC class I tetramers, C57BL/6 mice sensitized with BALB/c splenocytes were shown to harbor H-2K(d)-specific IgG(+) memory B cells with a post-germinal center phenotype (CD73(+)CD273(+)CD38(hi)CD138(-)GL7(-)). These memory B cells adoptively transferred into naive mice without memory T cells recapitulated class-switched recall alloantibody responses. During recall, memory H-2K(d)-specific B cells preferentially differentiated into Ab-secreting cells, whereas in the primary response, H-2K(d)-specific B cells differentiated into germinal center cells. Finally, our studies revealed that, despite fundamental differences in alloreactive B cell fates in sensitized versus naive recipients, CTLA-4Ig was unexpectedly effective at constraining B cell responses and heart allograft rejection in sensitized recipients.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 5'-Nucleotidase / analysis
  • Abatacept / pharmacology*
  • Allografts
  • Animals
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Graft Survival*
  • Heart Transplantation*
  • Immunologic Memory*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Programmed Cell Death 1 Ligand 2 Protein / analysis

Substances

  • Programmed Cell Death 1 Ligand 2 Protein
  • Abatacept
  • 5'-Nucleotidase